Recent studies have found that Src homolog and collagen homolog 3 (Shc3) are overexpressed in chemotherapy-resistant HCC and similarly activate this pathway, causing resistance to sorafenib and doxorubicin in HCC (168). This evidence concerns the gene SHC3 and hepatocellular carcinoma.